Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ameliorated Pap Tests and Cervical Cancer Screening Participation
Sponsor: National Taiwan University Hospital
Summary
The Pap test plays a crucial role in the early detection of cervical cancer. A pilot single-center randomized controlled trial applied the peak-end concept and added a non-painful step at the end of Pap smear screening, aimed to reduce recalled pain. However, there is still no multicenter study investigating the effect of the modified Pap test on cervical cancer screening participation. The present project is the first multicenter randomized controlled trial to expand the current scope of the peak-end theory into Pap tests and cervical cancer screening participation by adding a non-painful step at the end of Pap smear screening. Our multidisciplinary team (NTUH Pap Study Group) aims to provide innovative, feasible, and low-cost strategies for cervical cancer screening participation.
Official title: Effects of the Ameliorated Pap Test on Cervical Cancer Screening Participation: a Multicenter Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
25 Years - Any
Study Type
INTERVENTIONAL
Enrollment
248
Start Date
2026-03-01
Completion Date
2032-12-31
Last Updated
2026-03-03
Healthy Volunteers
No
Interventions
Modified Pap test
For the intervention group receiving the modified Pap test, instead of immediately removing the speculum just after rotating back the speculum, an operator still fixes the speculum in the vagina for 15 seconds.
Locations (5)
National Taiwan University Hospital Yunlin Branch
Douliu, Taiwan
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
National Taiwan University Cancer Center
Taipei, Taiwan
National Taiwan University Hospital Beihu Branch
Taipei, Taiwan